Gemma Eminowicz

ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer

Toon Van Gorp, David Cibula, Weiguo Lv et al. · Annals of Oncology · 2024 · 82 citations · Full text

Medicine, Oncology, Chemotherapy +4

Validation of clinical acceptability of an atlas‐based segmentation algorithm for the delineation of organs at risk in head and neck cancer

Albert K. Hoang Duc, Gemma Eminowicz, R. Mendes et al. · Medical Physics · 2015 · 75 citations · Full text

Medicine, Oncology, Radiology +17

Variability of clinical target volume delineation for definitive radiotherapy in cervix cancer

Gemma Eminowicz, Mary McCormack · Radiotherapy and Oncology · 2015 · 72 citations

Medicine, Oncology, Radiation Oncology +16

LBA8 A randomised phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE trial

Mary McCormack, D. Gallardo Rincón, Gemma Eminowicz et al. · Annals of Oncology · 2023 · 64 citations · Full text

Medicine, Oncology, Chemotherapy +13

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial

Christian Marth, Richard G. Moore, Mariusz Bidziński et al. · Journal of Clinical Oncology · 2024 · 58 citations · Full text

Medicine, Oncology, Pharmacotherapy +13